| Literature DB >> 15507126 |
W James Cook1, Martha F Kramer, Russell M Walker, Timothy J Burwell, Holly A Holman, Donald M Coen, David M Knipe.
Abstract
Inflammatory cytokines and infiltrating T cells are readily detected in herpes simplex virus (HSV) infected mouse cornea and trigeminal ganglia (TG) during the acute phase of infection, and certain cytokines continue to be expressed at lower levels in infected TG during the subsequent latent phase. Recent results have shown that HSV infection activates Toll-like receptor signaling. Thus, we hypothesized that chemokines may be broadly expressed at both primary sites and latent sites of HSV infection for prolonged periods of time. Real-time reverse transcriptase-polymrease chain reaction (RT-PCR) to quantify expression levels of transcripts encoding chemokines and their receptors in cornea and TG following corneal infection. RNAs encoding the inflammatory-type chemokine receptors CCR1, CCR2, CCR5, and CXCR3, which are highly expressed on activated T cells, macrophages and most immature dendritic cells (DC), and the more broadly expressed CCR7, were highly expressed and strongly induced in infected cornea and TG at 3 and 10 days postinfection (dpi). Elevated levels of these RNAs persisted in both cornea and TG during the latent phase at 30 dpi. RNAs for the broadly expressed CXCR4 receptor was induced at 30 dpi but less so at 3 and 10 dpi in both cornea and TG. Transcripts for CCR3 and CCR6, receptors that are not highly expressed on activated T cells or macrophages, also appeared to be induced during acute and latent phases; however, their very low expression levels were near the limit of our detection. RNAs encoding the CCR1 and CCR5 chemokine ligands MIP-1alpha, MIP-1beta and RANTES, and the CCR2 ligand MCP-1 were also strongly induced and persisted in cornea and TG during the latent phase. These and other recent results argue that HSV antigens or DNA can stimulate expression of chemokines, perhaps through activation of Toll-like receptors, for long periods of time at both primary and latent sites of HSV infection. These chemokines recruit activated T cells and other immune cells, including DC, that express chemokine receptors to primary and secondary sites of infection. Prolonged activation of chemokine expression could provide mechanistic explanations for certain aspects of HSV biology and pathogenesis.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15507126 PMCID: PMC524517 DOI: 10.1186/1743-422X-1-5
Source DB: PubMed Journal: Virol J ISSN: 1743-422X Impact factor: 4.099
Expression of Chemokine Receptors, Chemokines and Cytokines in Leukocyte Populations
| Chemokine receptors | Cell type expression | Chemokine ligand | Proposed primary function(s) |
| CCR1 | T cells, macrophages, immature dendritic cells (DC), natural killer cells (NK) | RANTES; MIP-1α; MCP-3, and 4; HCC-1, 2, and 4 | Migration of DC to sites of inflammation Recruitment of T cells, macrophages and NK |
| CCR2 | T cells, natural killer cells (NK), macrophages, immature DC | MCP-1, 3, and 4 | Migration of effector T cells (Th1) Migration of DC progenitors to sites of inflammation |
| CCR3 | eosinophils, basophils, T cells | eotaxin-1 and 2; RANTES; MCP-2, 3, and 4; HCC-2 | Recruitment of eosinophils |
| CCR5 | T cells (Th1, Tc1), macrophages, immature DC | RANTES; MIP-1α and 1β | Migration of effector T cells (Th1) Migration of DC to sites of inflammation Recruitment of macrophages |
| CCR6 | immature DC (CD34+/Langerhans-like), T cells | MIP-3α | Migration of DC to skin |
| CCR7 | T cells, B cells, mature DC | SLC, ELC | Migration of naïve T cells to lymph nodes Migration of memory T cells to lymphoid tissue |
| Migration of B cells Migration of DC to lymphoid tissues | |||
| CXCR3 | T cells (Th1, Tc1) | IP-10, MIG, ITAC | Migration of effector T cells (Th1) |
| CXCR4 | T cells, macrophages, DC, B cells, others including neurons | SDF-1 | Migration of effector T cells (Th2) |
| Migration of B cells | |||
| Migration of hematopoietic progenitors | |||
| Chemokines | Receptor | ||
| MIP-1α | T cells, NK, macrophages, others | CCR1, CCR5 | Chemoattract macrophages, T cells, NK, and others |
| MIP-1β | T cells, NK, macrophages, others | CCR5, CCR1 (weak) | Chemoattract macrophages, T cells, and others |
| RANTES | T cells, NK | CCR1, CCR5, CCR3 (weak) | Chemoattract T cells and others |
| MCP-1 | macrophages, others | CCR2 | Chemoattract macrophages, T cells, NK, and others |
| Eotaxin-1 | epithelial cells, NK, macrophages, others | CCR3 | Chemoattract eosinophils |
| Cytokines | Receptor | ||
| IFN-γ | T cells, NK | IFN-γR | Activation of antiviral response |
| TNF-α | macrophages, NK, others | TNF-R | Broad activation of antiviral and inflammatory response |
Primer and Probe Sequences
| Forward Primer | Reverse Primer | Probe* | |
| tk | CGAGACAATCGCGAACATCTAC | CCCCGGCCGATATCTCA | CCACACAACACCGCCTCGACCA |
| ICP0 | CTGCGCTGCGACACCTT | CAATTGCATCCAGGTTTTCATG | TGCATGCACCGCTTCTGCATCC |
| CCR1 | GGGTGAACGGTTCTGGAAGTAC | CAGCCATTTTGCCAGTGGTA | ACATGCCTTTGAAACAGCTGCCGAA |
| CCR2 | ATGAGTAACTGTGTGATTGACAAGCA | GCAGCAGTGTGTCATTCCAAGA | CTCTGTCACCTGCATGGCCTGGTCT |
| CCR3 | ACCAGCTGTGAGCAGAGTAAACAT | CACAGCAGTGGGTGTAGGCA | CACCTCAGTCACCTGCATGGCCA |
| CCR5 | ACTGCTGCCTAAACCCTGTCA | GTTTTCGGAAGAACACTGAGAGATAA | TCCGGAACTTCTCTCCAACAAAGGCA |
| CCR6 | TTGGTGCAGGCCCAGAAC | GAACACGAGAACCACAGCGAT | CCAAGAGGCACAGAGCCATCCGA |
| CCR7 | CTGCTACCTCATTATCATCCGTACCT | TGATCACCTTGATGGCCTTGT | CTCCAGGCACGCAACTTTGAGCG |
| CXCR3 | TGTAGTTGGGCTAGCTCGAACTT | ACCTGGATATATGCTGAGCTGTCA | GCATCCTGGCAGCAAAGTTACGGG |
| CXCR4 | CTCCAAGGGCCACCAGAA | GGCAAAGAAAGCTAGGATGAGG | CGCAAGGCCCTCAAGACGACAGTC |
| Chemokine | |||
| MIP-1α | TCATCGTTGACTATTTTGAAACCAG | GCCGGTTTCTCTTAGTCAGGAA | AGCCTTTGCTCCCAGCCAGGTGTC |
| MIP-1β | AGGGTTCTCAGCACCAATGG | GCTGCCGGGAGGTGTAAGA | CTCTGACCCTCCCACTTCCTGCTGTTT |
| RANTES | CTGTCATCGCTTGCTCTAGTCCTA | CGGATGGAGATGCCGATTT | ATCCCCTACTCCCACTCCGGTCCTG |
| MCP-1 | GCTGGGTTCAGTTTCCTTAAGC | CCTAGTCTTTAGCTGTGAGACCTTCTG | AGGCCTCGCTGCTCCACATCCA |
| Eotaxin-1 | CCTAAGACGTGCTCTGAGGGAAT | TCCCATCTGGAACTACATGAAGC | TCAGCACCAGTCGCCCAAGGACT |
| Cytokine | |||
| IFN-γ | TGAGTATTGCCAAGTTTGAGGTCA | GTGGACCACTCGGATGAGCT | CCACAGGTCCAGCGCCAAGCA |
| TNF-α | ACAAGGCTGCCCCGACTAC | CGCAGAGAGGAGGTTGACTT | CCTCACCCACACCGTCAGCCG |
* all probes FAM-5' and 3'-TAMRA
Figure 1HSV tk and ICP0 RNA expression in mock and HSV-infected cornea and TG. RNA isolated from tissues harvested at 3, 10, or 30 days postinfection (d) was subjected to TaqMan RT-PCR analysis using HSV tk primers/probe (A) and HSV ICP0 primers/probe (B) as described in Materials and Methods. Mouse GAPDH RNA was measured in multiplex reactions, and used to calculate relative expression using the formula Rel Exp= 2-(ΔΔCT) × 1000 as described in Materials and Methods. Shown below the plots are relative expression values and the CT value measured for tk (A) and ICPO (B) in each sample. The ICP0 signal detected at 10 and 30 dpi in HSV-infected TG is likely due to LAT RNA as described in the text. Results shown are for one experiment (Experiment #1) in which the number of individual mouse tissues pooled were 10 for cornea and 6 for TG. Similar results were obtained in two additional experiments (Experiment #2 and Experiment #3), except for variation in detection of tk RNA in infected TG at 30 dpi as described in the text.
Figure 2Relative levels of chemokine and chemokine receptor RNA expression in mock and HSV-infected cornea. Corneas were harvested at 3 (A), 10 (B), or 30 (C) days postinfection, and relative levels of expression were determined by TaqMan RT-PCR analysis as described in Fig. 1 and Materials and Methods. Results shown are the average of relative expression values determined using cDNA from two independent experiments, with each cDNA subjected to 2 or 3 separate measurements. Dashed bars represent ranges of individual values. Each cDNA was synthesized from RNA isolated from pooled corneas (5 mice) as described in Fig. 1 and Materials and Methods. The induction ratios (HSV+ vs. mock) for individual genes are tabulated in Table 3.
Induction Ratio (HSV+/Mock) of Transcripts for Chemokine Receptors, Chemokines and Cytokines in Cornea and Trigeminal Ganglia (TG)
| Corneaa | TGb | |||||
| Gene | 3d | 10d | 30d | 3d | 10d | 30d |
| CCR1 | 11 (9.2–12) | 18 (13–23) | 20 (10–26) | 5 (2.2–7.1) | 15 (9.0–19) | 4 (1.7–7.0) |
| CCR2 | 14 (9.2–19) | 22 (11–32) | 14 (8.1–24) | 3 (1.5–4.2) | 15 (11–19) | 3 (1.3–4.4) |
| CCR3 | 2 (1.0–5.0) | 3 (2.0–5.0) | 3 (2.5–3.3) | 2 (0.5–5.0) | 8 (2.2–20) | 3 (1.8–4.7) |
| CCR5 | 12 (12.3–12.5) | 11 (8.0–14) | 20 (8.9–36) | 9 (4.8–11) | 57 (22–110) | 9 (7.0–10) |
| CCR6 | 3 (2.4–3.0) | 2 (1.0–2.5) | 5 (1.5–8.5) | 3 (0.3–11) | 3 (1.0–5.0) | 14 (1.0–40) |
| CCR7 | 24 (8.0–40) | 5 (3.0–6.5) | 17 (13–21) | 13 (9.0–17) | 19 (17–20) | 7 (2.0–11) |
| CXCR3 | 10 (5.0–18) | 15 (8.0–23) | 5 (2.8–6.5) | 2 (1.0–4.0) | 104 (54–160) | 36 (14–59) |
| CXCR4 | 11 (4.8–14) | 3 (1.7–4.0) | 45 (33–74) | 0.6 (0.4–0.9) | 4 (2.9–6.2) | 3 (2.3–3.7) |
| MIP-1α | 69 (33–106) | 394 (263–1700) | 34 (16–53) | 232 (80–471) | 126 (80–168) | 25 (13–45) |
| MIP-1β | 53 (39–67) | 285 (261–310) | 16 (11–21) | 282 (10–595) | 230 (202–245) | 31 (24–37) |
| RANTES | 55 (36–73) | 43 (38–48) | 16 (12–18) | 64 (61–66) | 304 (302–306) | 31 (12–50) |
| MCP-1 | 54 (52–55) | 64 (55–74) | 12 (7.5–20) | 153 (113–194) | 22 (16–27) | 3 (1.6–4.2) |
| Eotaxin-1 | 3 (1.9–3.5) | 1 (0.6–1.3) | 3 (1.0–5.4) | 5 (3.3–9.1) | 2 (1.2–2.8) | 1.5 (0.7–2.3) |
| IFNγ | Inf.c | Inf. | Inf. | Inf. | Inf. | Inf. |
| TNF-α | 3 (2.9–3.0) | 3 (2.6–3.8) | 7 (3.9–12) | Inf. | Inf. | Inf. |
a Induction ratios were calculated as relative expression in HSV-infected/relative expression in mock-infected cornea. Each value is the average of induction ratios (2 or 3 separate measurements per cDNA sample) from two independent experiments. Ranges of individual ratios are in parentheses.
b Induction ratios were calculated for HSV- vs. mock-infected TG as in footnote a. Each value is the average of induction ratios (2 or 3 separate measurements per cDNA sample) from three independent experiments, with ranges in parentheses.
c Inf., infinite due to relative expression = 0 in all or most mock-infected samples.
Figure 3Relative levels of chemokine and chemokine receptor RNA expression in mock and HSV-infected TG. TG were harvested at 3 (A), 10 (B), or 30 (C) days postinfection, and RNA levels were determined by TaqMan RT-PCR analysis as described in Fig. 1, Fig. 2 and Materials and Methods. Results shown are the average of relative expression values determined using cDNA from three independent experiments, with each cDNA subjected to 2 or 3 separate measurements. Dashed bars represent ranges of individual values as described in Fig. 2. The induction ratios (HSV+ vs. mock) for individual genes are tabulated in Table 3.
Induction Ratio (HSV+/Mock) of Transcripts for Chemokine Receptors and Chemokines in Trigeminal Ganglia (TG) at Late Times Post-Infection
| Induction Ratioa | |||
| Gene | 45d | 62d | 90d |
| CCR2 | 3 (3.2–3.3) | 5 (1.3–8.8) | 2 (2.2–2.4) |
| CCR3 | 8 (5.0–12) | 3 (1.0–4.4) | 0.7 (0.4–1.0) |
| CCR5 | 5 (5.1–5.7) | 7 (4.9–9.0) | 5 (2.9–6.5) |
| CXCR3 | 17 (10–24) | 68 (25–111) | 20 (11–28) |
| MIP-1α | 10 (7.0–13) | 35 (4.0–67) | 4 (1.0–7.0) |
| Eotaxin-1 | 3 (1.5–3.9) | 2 (1.1–3.1) | 1.5 (0.8–2.3) |
a Induction ratios were calculated as relative expression in HSV-infected/relative expression in mock-infected cornea as described in Table 3. Each value is the average induction ratio (2 separate measurements per cDNA sample) from one experiment. Ranges of individual ratios are in parentheses.